Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease

Medicine and Dentistry

• Crohn's Disease 100%
• Tumor Necrosis Factor 100%
• Ulcerative Colitis 75%
• Endothelial Dysfunction 75%
• Inpatient 75%
• Serositis 50%
• Patient with Crohn's Disease 50%
• Acetylcholine 50%
• Vasodilatation 50%
• Cytokine 25%
• Pathophysiology 25%
• Neutralization 25%
• Interleukin 6 25%
• Inflammatory Bowel Disease 25%
• Drug 25%
• C Reactive Protein 25%
• Blood Vessel Reactivity 25%
• Sodium Nitroprusside 25%
• Chemotherapeutic Agent 25%
• Patient with Inflammatory Bowel Disease 25%
• Endothelial Function 25%
• Infliximab 25%
• Neutralizing Antibody 25%
• Marker 25%